Stonehouse Jon P 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Stonehouse Jon P
Director
Transactions
- Tax Payment
Common Stock
2025-12-12$7.57/sh−27,368$207,176→ 1,405,222 total
Holdings
- 30,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person.